drugset / Trial / NCT02305602
A Study of VentriGel in Post-MI Patients
NaSingle-groupOpen-labelTreatment
Summary
This Phase I, open label, study will investigate the effects of VentriGel injection in patients who have experienced a first, large ST elevation myocardial infarction (STEMI) treated by PCI within the past 3 years and have evidence of left ventricular remodeling.
Timeline
- Start
- 2015-09
- Primary completion
- 2018-09-05
- Completion
- 2019-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VentriGel | Other / unclassified | — | Other |